254 related articles for article (PubMed ID: 29135482)
1. Long-term darapladib use does not affect coronary plaque composition assessed using multimodality intravascular imaging modalities: a randomized-controlled study.
Choi WG; Prasad M; Lennon R; Gulati R; Prasad A; Lerman LO; Lerman A
Coron Artery Dis; 2018 Mar; 29(2):104-113. PubMed ID: 29135482
[TBL] [Abstract][Full Text] [Related]
2. Chronic inhibition of lipoprotein-associated phospholipase A
Prasad M; Lennon R; Barsness GW; Prasad A; Gulati R; Lerman LO; Lerman A
Int J Cardiol; 2018 Feb; 253():7-13. PubMed ID: 29306475
[TBL] [Abstract][Full Text] [Related]
3. Multimodality Intravascular Imaging to Evaluate Sex Differences in Plaque Morphology in Stable CAD.
Bharadwaj AS; Vengrenyuk Y; Yoshimura T; Baber U; Hasan C; Narula J; Sharma SK; Kini AS
JACC Cardiovasc Imaging; 2016 Apr; 9(4):400-7. PubMed ID: 27052268
[TBL] [Abstract][Full Text] [Related]
4. Multimodality imaging of attenuated plaque using grayscale and virtual histology intravascular ultrasound and optical coherent tomography.
Kang SJ; Ahn JM; Han S; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
Catheter Cardiovasc Interv; 2016 Jul; 88(1):E1-E11. PubMed ID: 25511369
[TBL] [Abstract][Full Text] [Related]
5. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque.
Serruys PW; García-García HM; Buszman P; Erne P; Verheye S; Aschermann M; Duckers H; Bleie O; Dudek D; Bøtker HE; von Birgelen C; D'Amico D; Hutchinson T; Zambanini A; Mastik F; van Es GA; van der Steen AF; Vince DG; Ganz P; Hamm CW; Wijns W; Zalewski A;
Circulation; 2008 Sep; 118(11):1172-82. PubMed ID: 18765397
[TBL] [Abstract][Full Text] [Related]
6. Is lipoprotein-associated phospholipase A2 activity correlated with fibrous-cap thickness and plaque volume in patients with acute coronary syndrome?
Gu X; Hou J; Yang S; Yu H; Tian J; Liu F; Li N; Yu B; Jang IK
Coron Artery Dis; 2014 Jan; 25(1):10-5. PubMed ID: 24089018
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Assessment of Coronary Plaque Progression With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear Stress: A Pilot Double-Blinded Randomized Controlled Clinical Trial of Nebivolol Versus Atenolol in Nonobstructive Coronary Artery Disease.
Hung OY; Molony D; Corban MT; Rasoul-Arzrumly E; Maynard C; Eshtehardi P; Dhawan S; Timmins LH; Piccinelli M; Ahn SG; Gogas BD; McDaniel MC; Quyyumi AA; Giddens DP; Samady H
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811165
[TBL] [Abstract][Full Text] [Related]
8. Multimodality Intracoronary Imaging With Near-Infrared Spectroscopy and Intravascular Ultrasound in Asymptomatic Individuals With High Calcium Scores.
Madder RD; VanOosterhout S; Klungle D; Mulder A; Elmore M; Decker JM; Langholz D; Boyden TF; Parker J; Muller JE
Circ Cardiovasc Imaging; 2017 Oct; 10(10):. PubMed ID: 28982647
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis.
García-García HM; Klauss V; Gonzalo N; Garg S; Onuma Y; Hamm CW; Wijns W; Shannon J; Serruys PW
Int J Cardiovasc Imaging; 2012 Apr; 28(4):695-703. PubMed ID: 21594650
[TBL] [Abstract][Full Text] [Related]
10. Genetic invalidation of Lp-PLA
Gregson JM; Freitag DF; Surendran P; Stitziel NO; Chowdhury R; Burgess S; Kaptoge S; Gao P; Staley JR; Willeit P; Nielsen SF; Caslake M; Trompet S; Polfus LM; Kuulasmaa K; Kontto J; Perola M; Blankenberg S; Veronesi G; Gianfagna F; Männistö S; Kimura A; Lin H; Reilly DF; Gorski M; Mijatovic V; ; Munroe PB; Ehret GB; ; Thompson A; Uria-Nickelsen M; Malarstig A; Dehghan A; ; Vogt TF; Sasaoka T; Takeuchi F; Kato N; Yamada Y; Kee F; Müller-Nurasyid M; Ferrières J; Arveiler D; Amouyel P; Salomaa V; Boerwinkle E; Thompson SG; Ford I; Wouter Jukema J; Sattar N; Packard CJ; Shafi Majumder AA; Alam DS; Deloukas P; Schunkert H; Samani NJ; Kathiresan S; ; Nordestgaard BG; Saleheen D; Howson JM; Di Angelantonio E; Butterworth AS; Danesh J;
Eur J Prev Cardiol; 2017 Mar; 24(5):492-504. PubMed ID: 27940953
[TBL] [Abstract][Full Text] [Related]
11. Multimodality Intravascular Imaging to Predict Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention.
Kini AS; Motoyama S; Vengrenyuk Y; Feig JE; Pena J; Baber U; Bhat AM; Moreno P; Kovacic JC; Narula J; Sharma SK
JACC Cardiovasc Interv; 2015 Jun; 8(7):937-45. PubMed ID: 26088511
[TBL] [Abstract][Full Text] [Related]
12. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive and invasive imaging of vulnerable coronary plaque.
Celeng C; Takx RA; Ferencik M; Maurovich-Horvat P
Trends Cardiovasc Med; 2016 Aug; 26(6):538-47. PubMed ID: 27079893
[TBL] [Abstract][Full Text] [Related]
14. Utility of Multimodality Intravascular Imaging and the Local Hemodynamic Forces to Predict Atherosclerotic Disease Progression.
Bourantas CV; Räber L; Sakellarios A; Ueki Y; Zanchin T; Koskinas KC; Yamaji K; Taniwaki M; Heg D; Radu MD; Papafaklis MI; Kalatzis F; Naka KK; Fotiadis DI; Mathur A; Serruys PW; Michalis LK; Garcia-Garcia HM; Karagiannis A; Windecker S
JACC Cardiovasc Imaging; 2020 Apr; 13(4):1021-1032. PubMed ID: 31202749
[TBL] [Abstract][Full Text] [Related]
15. In vivo coronary lesion differentiation with computed tomography angiography and intravascular ultrasound as compared to optical coherence tomography.
Wieringa WG; Lexis CP; Lipsic E; van der Werf HW; Burgerhof JG; Hagens VE; Bartels GL; Broersen A; Schurer RA; Tan ES; van der Harst P; van den Heuvel AF; Willems TP; Pundziute G
J Cardiovasc Comput Tomogr; 2017; 11(2):111-118. PubMed ID: 28169175
[TBL] [Abstract][Full Text] [Related]
16. Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study.
Staurenghi G; Ye L; Magee MH; Danis RP; Wurzelmann J; Adamson P; McLaughlin MM;
Ophthalmology; 2015 May; 122(5):990-6. PubMed ID: 25749297
[TBL] [Abstract][Full Text] [Related]
17. Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities.
Simsek C; Karanasos A; Magro M; Garcia-Garcia HM; Onuma Y; Regar E; Boersma E; Serruys PW; van Geuns RJ
EuroIntervention; 2016 Jan; 11(9):996-1003. PubMed ID: 25349042
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characterization of Coronary Atherosclerosis With Dual-Modality OCT and Near-Infrared Autofluorescence Imaging.
Ughi GJ; Wang H; Gerbaud E; Gardecki JA; Fard AM; Hamidi E; Vacas-Jacques P; Rosenberg M; Jaffer FA; Tearney GJ
JACC Cardiovasc Imaging; 2016 Nov; 9(11):1304-1314. PubMed ID: 26971006
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein cholesterol associated with change in coronary plaque lipid burden assessed by near infrared spectroscopy.
Honda S; Sidharta SL; Shishikura D; Takata K; Di Giovanni GA; Nguyen T; Janssan A; Kim SW; Andrews J; Psaltis PJ; Worthley MI; Nicholls SJ
Atherosclerosis; 2017 Oct; 265():110-116. PubMed ID: 28881268
[TBL] [Abstract][Full Text] [Related]
20. Intravascular ultrasound and optical coherence tomography imaging of coronary atherosclerosis.
Costopoulos C; Brown AJ; Teng Z; Hoole SP; West NE; Samady H; Bennett MR
Int J Cardiovasc Imaging; 2016 Jan; 32(1):189-200. PubMed ID: 26153522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
